People on the move
Cytovance Biologics
The biopharma contract manufacturing organisation Cytovance has appointed Don Wuchterl as Chief Operating Officer.
Wuchterl will oversee Cytovance's R&D services, manufacturing, warehouse, facilities, engineering, and programme management units.
The new COO joined Cytovance in July 2012 as Senior VP of Manufacturing Operations, before which he was Director of Manufacturing at Dendreon, responsible for the construction of its cellular immunotherapy manufacturing facility in Georgia.
He has also led manufacturing of Shire’s biopharmaceuticals, and worked for Amgen, Biogen and Roche.